BREAKING NEWS: CDC HEAD RESIGNS AFTER REPORT SHOWS SHE BOUGHT MERCK STOCK AFTER TAKING THE JOB

 In News

Dr. Brenda Fitzgerald’s resignation comes one day after reports* confirmed that she bought shares in pharmaceutical and tobacco companies one month into her job as director of the Centers for Disease Control and Prevention (CDC).

This comes as one more sign of the conflicts of interests rampant at the CDC, whose previous directors had close ties with the pharmaceutical industry they were meant to regulate.

Ex-CDC head Julie Gerberding, who nearly tripled the childhood vaccine schedule during her tenure, went to work for vaccine giant Merck directly after leaving the CDC. Two months into her Merck job, Gerberding sold more than $2 MILLION in stock, while holding onto thousands of shares worth another $2 million.

Another glaring conflict of interest between the CDC and the pharmaceutical industry is the fact that the CDC owns multiple vaccine patents. These patents are licensed to pharmaceutical and vaccine companies and generate MILLIONS in royalty income every year. The CDC Foundation, which does not clearly disclose its activities, takes in millions from pharmaceutical companies.

Still believe in the system?! We taxpayers are funding an agency that clearly puts money before it’s mission to keep America healthy. We can no longer trust an agency with such strong ties to the pharmaceutical industry — an industry that only makes money when we are sick.

Protect yourselves! LearnTheRisk.org

Read the main report: cdc-director-resigns-over-financial-conflicts

Besides Japan Tobacco, Fitzgerald also purchased tens of thousands of dollars in new stock in at least a dozen companies, including between $1,001 and $15,000 each in Merck & Co, Bayer and health insurance company Humana, as well as between $15,001 and $50,000 in US Food Holding Co. in the months after she was appointed CDC director, according to financial disclosure documents.”

Recent Posts

Leave a Comment

Contact Us

Questions about vaccines?? Want good resources? Need support?! Send us an email and we'll get back to you.

Not readable? Change text. captcha txt
0
Close
X